Topic List : Mental Health
Neuron-nudged mice see what isn’t there
Stanford scientists, using only direct brain stimulation, reproduced both the brain dynamics and the behavioral response of mice taught to discriminate between two different images.
Schatzberg urges caution with ketamine
Physicians and patients are excited about ketamine, the latest drug to treat depression, but Stanford psychiatrist Alan Schatzberg says we need to tread carefully.
Quashing myths about PTSD
Shaili Jain, a Stanford psychiatrist, discusses the explosion of knowledge about post-traumatic stress disorder and the condition’s widespread impact. PTSD is the subject of her new book, The Unspeakable Mind.
Study: Hormone improves social skills in autism
In a Stanford study of 30 children with autism, intranasal vasopressin improved social skills more than a placebo, suggesting that the hormone may treat core features of the disorder.
Brain networks predict PTSD treatment success
Clinicians may be able to determine whether people with post-traumatic stress disorder will respond to psychotherapy by analyzing a key brain network and memory, according to Stanford researchers.
Popular opioids fail patients on SSRIs
Patients taking antidepressants known as selective serotonin reuptake inhibitors do not respond well to hydrocodone, such as Vicodin, Stanford researchers report.
Effort to help teens with severe mental disorders
Stanford Children’s Health and the Children’s Health Council have launched RISE, an intensive mental health outpatient program for adolescents ages 14-18.
Ketamine tied to opioid system
Ketamine’s antidepressive effects require activation of opioid receptors in the brain, a new Stanford study shows. The surprising finding may alter how new antidepressants are developed and administered in order to mitigate the risk of opioid dependence.
Device helps kids with autism read looks
Wearing a device that identifies other people’s facial expressions can help children with autism develop better social skills, a Stanford pilot study has demonstrated.
Depression, blood levels of substance linked
Investigators at Stanford and elsewhere have shown, for the first time in humans, that low blood levels of acetyl-L-carnitine track with the severity and duration of depression.